Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease
Expert Review of Pharmacoeconomics & Outcomes Research（2022）
Key words
Streptococcus pneumoniae,vaccination,immunization,cost-effectiveness,pneumococcal conjugate vaccine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined